A critical cytoprotective role of endogenous adrenomedullin in acute myocardial infarction

Journal of Molecular and Cellular Cardiology

Volumn 41, Issue 2, 2006, Pages 360-363

  Hamid, Shabaz A ^a   Baxter, Gary F ^a  

^a ROYAL VETERINARY COLLEGE   (United Kingdom)

Author keywords

Adrenomedullin; Akt eNOS; Cardioprotection; Infarct; Ischaemia reperfusion

Indexed keywords

ADRENOMEDULLIN; TETRAZOLIUM;

ACUTE HEART INFARCTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROTECTION; CONTROLLED STUDY; EVIDENCE BASED MEDICINE; FEMALE; HEART INFARCTION; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; MALE; MOUSE; NONHUMAN; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; REGULATORY MECHANISM; REPERFUSION INJURY; SIGNAL TRANSDUCTION; STATISTICAL ANALYSIS; SURVIVAL; WILD TYPE;

ADRENOMEDULLIN; ANIMALS; FEMALE; GENE EXPRESSION REGULATION; MALE; MICE; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; NITRIC OXIDE SYNTHASE TYPE II; ONCOGENE PROTEIN V-AKT; PEPTIDES; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION;

EID: 33746048039     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2006.05.017     Document Type: Article

References (13)

1. Oie E., Vinge L.E., Anderson G.O., Yndestad A., Krobert K.A., Sandeberg C., et al. RAMP2 and RAMP3 mRNA levels are increased in failing rat cardiomyocytes and associated with increased responsiveness to adrenomedullin. J Mol Cell Cardiol 38 (2005) 145-151
2. Richards A.M., Doughty R., Nicolls M.G., MacMahon S., Sharp N., Murphy J., et al. Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: prognostic utility and prediction of benefit from carvedilol in chronic ischemic left ventricular dysfunction. Australia-New Zealand Heart Failure Group. J Am Coll Cardiol 37 (2001) 1781-1787
3. Hamid S.A., and Baxter G.F. Adrenomedullin: regulator of systemic and cardiac homeostasis in acute myocardial infarction. Pharmacol Ther 105 (2005) 95-112
4. Kato K., Yin H., Agata J., Yoshida H., Chao L., and Chao J. Adrenomedullin gene delivery attenuates myocardial infarction and apoptosis after ischemia and reperfusion. Am J Physiol, Heart Circ Physiol 285 (2003) H1506-H1514
5. Nagaya N., Nishikimi T., Yoshihara F., Horio T., Morimoto A., and Kangawa K. Cardiac adrenomedullin gene expression and peptide accumulation after acute myocardial infarction in rats. Am J Physiol, Regul Integr Comp Physiol 278 (2000) R1019-R1026
6. Yin H., Chao L., and Chao J. Adrenomedullin protects against myocardial apoptosis after ischemia/reperfusion through activation of Akt-GSK signaling. Hypertension 43 (2004) 109-116
7. Hamid S.A., and Baxter G.F. Adrenomedullin limits reperfusion injury in experimental myocardial infarction. Basic Res Cardiol 100 (2005) 387-396
8. Nakamure R., Kato J., Kitamura K., Onitsuka H., Imamura, Cao Y., et al. Adrenomedullin administration immediately after myocardial infarction ameliorates progression of heart failure in rats. Circulation 110 (2004) 426-431
9. Okumura H., Nagaya N., Itoh T., Okano I., Hino J., Mori K., et al. Adrenomedullin infusion attenuates myocardial ischemia/reperfusion injury through the phosphatidylinositol 3-kinase/Akt-dependent pathway. Circulation 109 (2004) 242-248
10. Niu P., Shindo T., Iwata H., Ebihara H., Suematsu Y., Zhang Y., et al. Accelerated cardiac hypertrophy and renal damage induced by angiotensin II in adrenomedullin knockout mice. Hypertens Res 26 (2003) 731-736
11. Shimosawa T., Shibagaki Y., Ishibashi K., Kitamura K., Kangawa K., Kato S., et al. Adrenomedullin, an endogenous peptide, counteracts cardiovascular damage. Circulation 105 (2002) 106-111
12. Shindo T., Kurihara Y., Nishimatsu H., Moriyama N., Kakoki M., Wang Y., et al. Vascular abnormalities and elevated blood pressure in mice lacking adrenomedullin gene. Circulation 104 (2001) 1964-1971
13. Hausenloy D.J., and Yellon D.M. New directions for protecting the heart against ischaemia-reperfusion injury: targeting the Reperfusion Injury Salvage Kinase (RISK)-pathway. Cardiovasc Res 61 (2004) 448-460